Translational Neurodegeneration

Naomi P. Visanji, et al.

Beyond the synucleinopathies: alpha synuclein as a driving force in neurodegenerative comorbidities

LPETTET / Getty Images / iStock

The interplay of aging, genetics and environmental factors in the pathogenesis of Parkinson’s disease

Articles

Recent

Oscillation-specific nodal alterations in early to middle stages Parkinson’s disease

Authors: Xiaojun Guan, Tao Guo, Qiaoling Zeng, Jiaqiu Wang, Cheng Zhou, Chunlei Liu, Hongjiang Wei, Yuyao Zhang, Min Xuan, Quanquan Gu, Xiaojun Xu, Peiyu Huang, Jiali Pu, Baorong Zhang and Min-Ming Zhang

Content type: Research

15 November 2019
Lower serum expression of miR-181c-5p is associated with increased plasma levels of amyloid-beta 1–40 and cerebral vulnerability in normal aging

Authors: Marta Manzano-Crespo, Mercedes Atienza and Jose L. Cantero

Content type: Research

4 November 2019
Transplantation of bone marrow derived macrophages reduces markers of neuropathology in an APP/PS1 mouse model

Authors: Luís Costa-Marques, Katrin Arnold, Marie-Christine Pardon, Christiane Leovsky, Samantha Swarbrick, Claire Fabian and Alexandra Stolzing

Content type: Research

14 October 2019
Exploratory study on microRNA profiles from plasma-derived extracellular vesicles in Alzheimer’s disease and dementia with Lewy bodies

Authors: Ana Gámez-Valero, Jaume Campdelacreu, Dolores Vilas, Lourdes Ispierto, Ramón Reñé, Ramiro Álvarez, M. Pilar Armengol, Francesc E. Borràs and Katrin Beyer

Content type: Research

4 October 2019
Bee venom phospholipase A2 ameliorates amyloidogenesis and neuroinflammation through inhibition of signal transducer and activator of transcription-3 pathway in Tg2576 mice

Authors: Hyeon Joo Ham, Sang-Bae Han, Jaesuk Yun, In Jun Yeo, Young Wan Ham, Se Hyun Kim, Pil-Hoon Park, Dong-Young Choi and Jin Tae Hong

Content type: Research

2 October 2019

Most recent articles RSS

View all articles

Editor-in-Chief

Shengdi Chen, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China

Journal news

For new submissions from 1st January 2019, authors will need to pay an article publishing charge (APC) of £1690.00/$2400.00/€2040.00 for each article submitted and accepted for publication in the journal.

Aims and Scope

Translational Neurodegeneration is an open access, peer-reviewed journal that covers research, therapeutics and education for all aspects of neurodegenerative diseases. By offering a high-visibility forum for new insights and discussions, Translational Neurodegeneration creates a novel interface between the fields of basic, translational, and clinical research. It includes Parkinson's disease and movement disorders, Alzheimer's disease and other dementias, motor neuron disease and other neurodegenerative diseases.

Translational Neurodegeneration

Beyond the synucleinopathies: alpha synuclein as a driving force in neurodegenerative comorbidities

The interplay of aging, genetics and environmental factors in the pathogenesis of Parkinson’s disease

Articles

Oscillation-specific nodal alterations in early to middle stages Parkinson’s disease

Lower serum expression of miR-181c-5p is associated with increased plasma levels of amyloid-beta 1–40 and cerebral vulnerability in normal aging

Transplantation of bone marrow derived macrophages reduces markers of neuropathology in an APP/PS1 mouse model

Exploratory study on microRNA profiles from plasma-derived extracellular vesicles in Alzheimer’s disease and dementia with Lewy bodies

Bee venom phospholipase A2 ameliorates amyloidogenesis and neuroinflammation through inhibition of signal transducer and activator of transcription-3 pathway in Tg2576 mice

Editor-in-Chief

Journal news

Aims and Scope

Affiliated with

Annual Journal Metrics

Translational Neurodegeneration

Contact us